These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 85354)

  • 1. No significant correlation of HLA-B8 and amount of antibodies directed to acetylcholine receptor protein in patients with myasthenia gravis.
    Smith CI; Hammarström L; Möller E; Lefvert AK; Matell G
    Tissue Antigens; 1978 Nov; 12(5):387-95. PubMed ID: 85354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis.
    Naeim F; Keesey JC; Herrmann C; Lindstrom J; Zeller E; Walford RL
    Tissue Antigens; 1978 Nov; 12(5):381-6. PubMed ID: 85353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
    Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
    Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
    Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
    J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
    Seybold ME; Baergen RN; Nave B; Lindstrom JM
    Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.
    Bartoccioni E; Scuderi F; Scoppetta C; Evoli A; Tonali P; Guidi L; Bartoloni C; Terranova T
    J Neurol; 1980; 224(1):9-15. PubMed ID: 6157802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gm allotypes in Swedish myasthenia gravis patients.
    Smith CI; Grubb R; Hammarström L; Matell G
    J Immunogenet; 1983 Feb; 10(1):1-9. PubMed ID: 6601678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
    Lebrun-Grandie P; Souan ML; Geffard M; Dartigues JF; Mauricet B; Orgogozo JM
    Presse Med; 1987 Oct; 16(32):1577-80. PubMed ID: 2958833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis.
    Roses AD; Olanow CW; McAdams MW; Lane RJ
    Neurology; 1981 Feb; 31(2):220-4. PubMed ID: 7193309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
    Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
    Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
    Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
    Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seronegative generalized myasthenia gravis: low frequency of thymic pathology.
    Verma PK; Oger JJ
    Neurology; 1992 Mar; 42(3 Pt 1):586-9. PubMed ID: 1296581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.